Henry E. Pelish - 29 Aug 2025 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role: Chief Scientific Officer
Signature: /s/ Nathan N. McConarty, attorney-in-fact
Issuer symbol: NUVL
Transactions as of: 29 Aug 2025
Net transactions value: +$4,986
Form type: 4
Filing time: 03 Sep 2025, 16:30:17 UTC
Previous filing: 08 Aug 2025
Next filing: 12 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Pelish Henry E.	Chief Scientific Officer	C/O NUVALENT, INC., ONE BROADWAY, 14TH FLOOR, CAMBRIDGE	/s/ Nathan N. McConarty, attorney-in-fact	03 Sep 2025	0002029477

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVL	Class A Common Stock	Options Exercise	$1,746	+2,007	+3.3%	$0.8700	62,963	29 Aug 2025	Direct
transaction	NUVL	Class A Common Stock	Options Exercise	$3,240	+3,000	+4.8%	$1.08	65,963	29 Aug 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVL	Stock Option (Right to Buy)	Options Exercise	$0	-2,007	-100%	$0.000000	0	29 Aug 2025	Class A Common Stock	2,007	$0.8700	Direct	F1
transaction	NUVL	Stock Option (Right to Buy)	Options Exercise	$0	-3,000	-37%	$0.000000	5,085	29 Aug 2025	Class A Common Stock	3,000	$1.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying this option are fully vested.